Skip to content
2000
Volume 10, Issue 13
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Histone Deacetylases (HDACs) enzymes are critical in regulating gene expression and transcription. They also play a fundamental role in regulating cellular activities such as cell proliferation, survival and differentiation. Inhibition of HDACs has generated many fascinating results including a new strategy in human cancer therapy. HDAC Inhibitors (HDACIs) like SAHA, TSA are emerging as new promising drugs for various anti-inflammatory and CNS-disorders. This review, along with chemical classification, emphasizes on the therapeutic potential of various HDACIs against different diseases.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955710793177296
2010-11-01
2025-10-27
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955710793177296
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test